Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery.
Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery.
复制标题
DOI:
10.1097/pcc.0b013e3181e30d43
复制
发表时间:
2011-01
期刊:
影响因子:
--
通讯作者:
Newburger JW
中科院分区:
文献类型:
--
作者:
Kipps AK;Wypij D;Thiagarajan RR;Bacha EA;Newburger JW
Perioperative transfusion has adverse effects in adults undergoing cardiac surgery. We sought to investigate whether greater use of blood and blood products might be an independent predictor of prolonged postoperative recovery, indicated by duration of mechanical ventilation (DMV), after reparative infant heart surgery. Prospectively collected data on 270 infants from two randomized trials of hematocrit strategy during cardiopulmonary bypass in infant heart surgery were analyzed to explore the association of DMV with perioperative transfusion and other variables. In univariable analyses, longer DMV was associated with younger age and lower weight at surgery, diagnostic group, and higher intraoperative and postoperative blood product transfusion (each p<0.001). In multivariable proportional hazard regression, longer total support time and greater intraoperative and early postoperative blood products per kg were the strongest predictors of longer DMV. Patients in the highest tertile of intraoperative blood products per kg had an instantaneous risk of being extubated approximately half that of patients in the lowest tertile (hazard ratio=0.51, 95% CI 0.35, 0.73). Patients who received any blood products postoperative day 1, compared to those who did not, had a hazard ratio for extubation of 0.65 (95% CI 0.50, 0.85). In this exploratory secondary analysis of infants undergoing two ventricular repair of congenital heart disease without aortic arch obstruction, greater intraoperative and early postoperative blood transfusion emerged as potential important risk factors for longer DMV. Future prospective clinical trials are needed to determine whether reduction in blood product administration hastens postoperative recovery after infant heart surgery.